Abstract:Background: Metabolic syndrome is the cluster of risk factors that leads to increased episodes of cardiovascular disease (CVD). These risk factors include but are not limited to obesity, non-alcoholic fatty liver (NAFLD), dyslipidemia, and type 2 diabetes. Since the pathogenesis of metabolic syndrome has multiple metabolic origins, there is no single treatment for it. Pharmacological approaches consist of separate drugs which target at individual risk factors which pose various side effects. Functional foods or nutraceuticals which have potentially important anti-obesity properties have thus attracted great attention. Schisandrae Fructus is a Chinese herb traditionally used as a liver tonic. Silymarin, an extract of the milk thistle (Silybum marianum), is a dietary supplement that is widely used in western society for the prevention and treatment of liver problems. Crataegus Fructus (hawthorn) is traditionally used to promote digestion and dissipate food stagnation. Momordica charantia (bitter melon) is traditionally used for treatment of diabetes in Ayurvedic Medicine. Hypothesis/purpose: We aimed to develop a multi-targeted herbal formula to target on the multiple risk factors of metabolic syndrome using individual herbs. This proposed herbal formula include sylimarin and Schisandrae Fructus, for NAFLD; Crataegus Fructus for obesity and hyperlipidemia; and Momordica charantia for hyperglycemia. Study design and methods: For in vitro study, we carried out insulin-induced 3T3-L1 adipocytes differentiation and fluorescent tagged cholesterol-treated Caco-2 cell assay to study for adipogenesis and cholesterol uptake into Caco-2 cells, respectively. Oleic acid-induced HepG2 cell assay was used to study for oleic acid-induced fatty liver, and brush border membrane vesicles (BBMV) assay was used to study for glucose uptake from the gut. For in vivo study, we performed an 8-week and a 12-week treatment studies, with each study comprising of 4 groups of C57Bl/6 male mice given: (i) Normal-chow diet; (ii)-(iv) High-fat diet (contains 21% fat and 0.15% cholesterol). After the initial 8 weeks of normal chow or high-fat diet feeding to induce obesity, animals were given: (i) Normal-chow diet; (ii) High-fat diet; (iii) High-fat diet + 2% herbal formula; or (iv) High-fat diet + 4% herbal formula as treatment for another 8 weeks or 12 weeks. Results: Our in vitro results suggested Crataegus Fructus aqueous extract exerted potent inhibitory effects on 3T3-L1 preadipocytes differentiation and cholesterol uptake into Caco-2 cells. Schisandrae Fructus aqueous extract and milk thistle exerted inhibitory effects on oleic acid-induced fatty liver in HepG2 cells. Momordica charantia extract on the other hand, exerted significant inhibitory effect on glucose uptake into BBMV. Our in vivo results showed that our herbal formula exhibited a trend to reduce diet-induced increase in body weight and fat pad mass (epididymal, perirenal and inguinal fat); and significantly reduced diet-induced increase in liver weight, liver lipid, and plasma lipid dose-dependently. Besides, high-fat diet induced a significant reduction in adiponectin level which was significantly improved by herbal formula supplementation at 4%. There was however no significant effect of the herbal formula on diet-induced increase in plasma glucose or insulin levels at either dose. Herbal formula also significantly reduced diet-induced inflammation in the liver at both doses. Conclusions: Taken together, these data suggested the potential of our novel multi-targeted herbal formula to be used as a therapeutic agent for diet-induced metabolic syndrome, with special emphasis on NAFLD.

[Design method of constitution regulating and healthcare foods based on medicinal property combination mode].

Treatment of Allergic Diseases with Constitution-Regulating Drug Pairs from the Point of View of Latent Pathogenic Factors Causing Disease

Mining Core Herbs and Their Combination Rules Using Effect Degree

Design of Multi-Drug Combinations for Poly-Pharmacological Effects Using Composition-Activity Relationship Modeling and Multi-Objective Optimization Approach: Application in Traditional Chinese Medicine

Functional Compounds Rapid Screening Strategy for Health Food Function-Formula-component Integrated Quality Control by Syndrome Correlation-Network Analysis

Systems Pharmacology Dissection of Multi-Scale Mechanisms of Action of Huo-Xiang-Zheng-Qi Formula for the Treatment of Gastrointestinal Diseases.

Conception of Chinese herbal compounds in treating dermatosis of healthy qi deficiency and excessive pathogen based on means of famous doctors' prescription digging

The Improving Application of Uniform Design on Refine Selection of Small Complex Prescription of Chinese Medicine

[Study on Function Evaluation of Health Food Containing Chinese Materia Medica Based on Data Mining].

Deciphering the combination principles of Traditional Chinese Medicine from a systems pharmacology perspective based on Ma-huang Decoction.

Multi-Objective and Fuzzy Optimization of the Different Ratios of Danshen (Salvia miltiorrhiza) to Sanqi (Panax notoginseng) in Composing Formulas

A novel methodology for multicomponent drug design and its application in optimizing the combination of active components from Chinese medicinal formula Shenmai.

Corresponding Relationship between Prescription and Syndrome in Traditional Chinese Medicial Practice

A new experimental design for screening Chinese medicine formula.

Comprehensive Summary of Material Basis-Laying a Foundation for Substances of Medicine Food Homology Development

An in vitro and in vivo study of a 4-herb formula on the management of diet-induced metabolic syndrome

A System-Level Investigation into the Mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for Cardiovascular Disease Treatment

[Some Thoughts on Health Food Formulated with Traditional Chinese Medicine].

Optimization of the prescription of Yueanjian by a uniform design

Chemical Constituents and Effective Substances of Traditional Chinese Medicinal Formula

Design Method of Master Protocol of Clinical Study on Diseases of Same Syndrome Type in Chinese Medicine